The World Health Organization (WHO) has announced that the number of people at risk of trachoma, has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91%.
WHO, in its website said a new data presented on Thursday at the 22nd meeting of the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020) also show that the number of people requiring surgery for trachomatous trichiasis – the late, blinding stage of trachoma – has dropped from 7.6 million in 2002 to 2.5 million in 2019, a reduction of 68%.
“Eliminating trachoma contributes to the ocular health and quality of life of the poorest, most disadvantaged people worldwide and thereby moves us a step closer to achieving universal health coverage,” said Dr Mwelecele Ntuli Malecela, Director, WHO Department of Control of Neglected Tropical Diseases.
“Ridding the world of this painful, debilitating disease is being made possible through generous donations of the antibiotic azithromycin, sustained contributions from a network of dedicated funding agencies and partners, and the efforts of hundreds of thousands of front-line workers who work tirelessly to engage communities and deliver interventions, Dr Malecela added.
Trachoma which is caused by infection with a bacterium remains endemic in 44 countries and has blinded or visually impaired around 1.9 million people worldwide.
“Eliminating trachoma has immediate benefit in preserving vision for people at risk. But work against trachoma has required the creation of innovative partnerships, which will help ensure that the most remote and marginalized people are not left behind as more comprehensive health services are strengthened,” said Mr Scott McPherson, Chair, International Coalition for Trachoma Control.
In 2018 alone, 146112 cases of trichiasis were managed and almost 90 million people were treated with antibiotics for trachoma in 782 districts worldwide.
Since 2011, eight countries have been validated by WHO as having eliminated trachoma as a public health problem.
“This is great progress, but we cannot afford to become complacent. We should be able to relegate trachoma to the history books in the next few years, but we will only do so by redoubling our efforts now. The last few countries are likely to be the hardest,” said Dr Anthony Solomon, Medical Officer in charge of WHO’s global trachoma elimination programme.
Trachoma is a disease of the eye caused by infection with the bacterium Chlamydia trachomatis. Transmission occurs through contact with infective discharges from the eyes and nose, particularly in young children who harbour the main reservoir of infection. It is also spread by flies which have been in contact with the eyes and noses of infected people.
The immune system can clear a single episode of infection, but in endemic communities the organism is frequently reacquired.
After years of repeated infection, the inside of the eyelid can become so severely scarred (trachomatous conjunctival scarring) that it turns inwards and causes the eyelashes to rub against the eyeball (trachomatous trichiasis), resulting in constant pain and light intolerance.
This and other alterations of the eye can lead to scarring of the cornea.
Left untreated, this condition leads to the formation of irreversible opacities, with resulting visual impairment or blindness.